Place of Origin : Shaoxing,China
Delivery Time : 3-7days
Product Capacity : 10kg/month
Payment Terms : TT
Quick Details
ProName: Liraglutide CAS NO 204656-20-2
Molecular Formula: C172H265N43O51
Appearance: white powder
Application: peptide,custom peptides,cosmetic peptides,GMP peptides,catalog peptides,oxytocin
PackAge: As customer's requires
Port: SHANGHAI
Purity: 98%
Impurity: 2%
Storage: 2«-8«
Transportation: Normal transport
LimitNum: 1 Gram
QUICK OVERVIEW
Product Name Liraglutide;
Cas No. 204656-20-2;
Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(N-ε-(Nα-Palmitoyl-L-γ-glutamyl))-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH;
Molecular Formula C172H265N43O51;
Molar Mass 3751.202 G/mol;
Purity ≥98%;
Impurity ≤0.5% ;
Storage Temperature 2-8?;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle Or At Customers Reqirement.
Function: Liraglutide Is For The Treatment Of Diabetes Type 2.
Mechanism Of Actions: Liraglutide Is A Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Indicated To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus, And To Reduce The Risk Of Heart Attack, Stroke And CV Death In Adults With Type 2 Diabetes And Established CV Disease.
It Was Approved By The FDA On December 23, 2014 And By The European Medicines Agency On January 23, 2015, For Adults With A Body Mass Index (BMI) Of 30 Or Greater (obesity) Or A BMI Of 27 Or Greater (overweight) Who Have At Least One Weight-related Condition.
Originator Company: Novo Nordisk
Dosage For Finished Formulation: 18 Mg/3ml
Similar Effect Peptides: Exenatide, Semaglutide
Generic API Process In Our Company: Liraglutide Is One Of Our Main Peptide Projects, Related Documents Will Be Submitted To The International FDA.
